Akari Therapeutics Plc (AKTX) Net margin 2022–2023
Akari Therapeutics Plc (AKTX) net profit margin by fiscal year — reported net income divided by reported revenue.
-2720.5%FY2023 · since FY2022: -2920.6% → -2720.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -2720.5% | +200.1 pp |
| FY2022 | -2920.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AKTX financial trends
AKTX RevenueAKTX Net incomeAKTX Gross profitAKTX Gross marginAKTX Operating incomeAKTX Operating marginAKTX Operating cash flowAKTX Free cash flowAKTX Capital expendituresAKTX Return on equityAKTX Stock buybacksAKTX Dividends paidAKTX Total assetsAKTX Total liabilitiesAKTX Shareholders’ equityAKTX overview →